Click HERE for Coronavirus COVID-19 Links for the UCSF Cancer Community

Pancreatic Cancer Cells Hijack Muscle Protein to Beef Up Their Metabolism

April 1, 2021 | Cancer starts with mutations in a cell’s DNA, but new UC San Francisco research shows that the endurance of a tumor relies on its ability to rapidly evolve and adapt to challenges brought about by the environment in which it grows.

How Inequities Fueled the COVID-19 Pandemic – And What We Can Do About It

March 22, 2021 | A panel of health experts and government officials addressed the myriad issues related to COVID-19, including health disparities before and during the pandemic, public partnerships, and how communities can better address inequities to prevent the next crisis.

Inspiration and Determination Mark COVID Anniversary

March 16, 2021 | One year after the declaration of the pandemic and San Franciscoʻs shelter-in-place order, members from every corner of the Cancer Center shared their lessons learned on change, adaptation, and resilience.

Christine Miaskowski Honored by NCI As Champion of Supportive Care Science

March 1, 2021 | In commemoration of the 50th Anniversary of the National Cancer Act, the Division of Cancer Prevention honors Christine Miaskowski, RN, PhD, FAAN, as a champion and changemaker of cancer prevention, early detection and symptom science.

Pandemic Brings Career Setbacks for Women in Medicine

February 17, 2021 | Women in academic medicine are facing the prospect of career setbacks as a result of the COVID-19 pandemic. A recently published Viewpoint article in JAMA Oncology by UCSF physician-scientists addressed the issue and offered solutions for institutions.

New Test Predicts Tumors Most Likely to Respond to Radiation, Chemotherapy

February 12, 2021 | Many cancer patients might respond better to treatments with the help of a new prognostic indicator based on a distinctive pattern of gene activity within tumor cells, according to a new study of human cancer data and experiments on human cancer cell lines grown in the lab.

Response to Cancer Immunotherapy May Be Affected by Genes We Carry from Birth

February 11, 2021 | Source: UCSF.edu. A new study finds that inherited genetic variation plays a role in who is likely to benefit from checkpoint inhibitors, which release the immune system’s brakes so it can attack cancer.